Relation between plasma antioxidant vitamin levels, adiposity and cardio-metabolic profile in adolescents: Effects of a multidisciplinary obesity programme

Published:November 07, 2015DOI:


      Background & aims

      In vivo and in vitro evidence suggests that antioxidant vitamins and carotenoids may be key factors in the treatment and prevention of obesity and obesity-associated disorders. Hence, the objective of the present study was to determine the relationship between plasma lipid-soluble antioxidant vitamin and carotenoid levels and adiposity and cardio-metabolic risk markers in overweight and obese adolescents participating in a multidisciplinary weight loss programme.


      A therapeutic programme was conducted with 103 adolescents aged 12–17 years old and diagnosed with overweight or obesity. Plasma concentrations of α-tocopherol, retinol, β-carotene and lycopene, anthropometric indicators of general and central adiposity, blood pressure and biochemical parameters were analysed at baseline and at 2 and 6 months of treatment.


      Lipid-corrected retinol (P < 0.05), β-carotene (P = 0.001) and α-tocopherol (P < 0.001) plasma levels increased significantly, whereas lipid-corrected lycopene levels remained unaltered during the treatment. Anthropometric indicators of adiposity (P < 0.001), blood pressure (P < 0.01) and biochemical parameters (P < 0.05) decreased significantly, whereas fat free mass increased significantly (P < 0.001). These clinical and biochemical improvements were related to changes in plasma lipid-corrected antioxidant vitamin and carotenoid levels. The adolescents who experienced the greatest weight loss also showed the largest decrease in anthropometric indicators of adiposity and biochemical parameters and the highest increase in fat free mass. Weight loss in these adolescents was related to an increase in plasma levels of lipid-corrected α-tocopherol (P = 0.001), β-carotene (P = 0.034) and lycopene (P = 0.019).


      Plasma lipid-soluble antioxidant vitamin and carotenoid levels are associated with reduced adiposity, greater weight loss and an improved cardio-metabolic profile in overweight and obese adolescents.



      ApoA1 (apolipoprotein A1), ApoB (apolipoprotein B), BMI (body mass index), CRP (C-reactive protein), CVD (cardiovascular diseases), DBP (diastolic blood pressure), FFM (fat free mass), FMI (fat mass index), HDL (high density lipoprotein), LC (lipid-corrected), LDL (low density lipoprotein), SDS-BMI (BMI standard deviation score), SBP (systolic blood pressure), TAG (triacylglycerols), UHPLC (Ultra High Performance Liquid Chromatography)
      To read this article in full you will need to make a payment
      Subscribe to Clinical Nutrition
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • WHO
        Population-based prevention strategies for childhood obesity: report of a WHO forum and technical meeting.
        World Health Organization, Geneva2010
        • Mathieu P.
        • Lemieux I.
        • Després J.P.
        Obesity, inflammation, and cardiovascular risk.
        Clin Pharmacol Ther. 2010; 87: 407-416
        • L'Allemand-Jander D.
        Clinical diagnosis of metabolic and cardiovascular risks in overweight children: early development of chronic diseases in the obese child.
        Int J Obes. 2010; 34: S32-S36
        • Gordon-Larsen P.
        • Adair L.S.
        • Nelson M.C.
        • Popkin B.M.
        Five-year obesity incidence in the transition period between adolescence and adulthood: the National Longitudinal Study of Adolescent Health.
        Am J Clin Nutr. 2004; 80: 569-575
        • Codoñer-Franch P.
        • Boix-García L.
        • Simó-Jordá R.
        • del Castillo-Villaescusa C.
        • Maset-Maldonado J.
        • Valls-Bellés V.
        Is obesity associated with oxidative stress in children?.
        Int J Pediatr Obes. 2010; 5: 56-63
        • Molnar D.
        • Decsi T.
        • Koletzko B.
        Reduced antioxidant status in obese children with multimetabolic syndrome.
        Int J Obes. 2004; 28: 1197-1202
        • Yasmeen R.
        • Jeyakumar S.M.
        • Reichert B.
        • Yang F.
        • Ziouzenkova O.
        The contribution of vitamin A to autocrine regulation of fat depots.
        Biochim Biophys Acta. 2012; 1821: 190-197
        • Lobo G.P.
        • Amengual J.
        • Li H.N.M.
        • Golczak M.
        • Bonet M.L.
        • Palczewski K.
        • et al.
        β,β-Carotene decreases peroxisome proliferator receptor γ activity and reduces lipid storage capacity of adipocytes in a β,β-carotene oxygenase 1-dependent manner.
        J Biol Chem. 2010; 285: 27891-27899
        • Gouranton E.
        • Thabuis C.
        • Riollet C.
        • Malezet-Desmoulins C.
        • El Yazidi C.
        • Amiot M.J.
        • et al.
        Lycopene inhibits proinflammatory cytokine and chemokine expression in adipose tissue.
        J Nutr Biochem. 2011; 22: 642-648
        • Pipaliya H.
        • Vaghasiya J.
        Cardio protective effect of vitamin a against isoproterenol-induced myocardial infarction.
        J Nutr Sci Vitaminol (Tokyo). 2012; 58: 402-407
        • Palozza P.
        • Parrone N.
        • Catalano A.
        • Simone R.
        Tomato lycopene and inflammatory cascade: basic interactions and clinical implications.
        Curr Med Chem. 2010; 17: 2547-2563
        • Mordente A.
        • Guantario B.
        • Meucci E.
        • Silvestrini A.
        • Lombardi E.E.
        • Martorana G.
        • et al.
        Lycopene and cardiovascular diseases: an update.
        Curr Med Chem. 2011; 18: 1146-1163
        • Stahl W.
        • Junghans A.
        • de Boer B.
        • Driomina E.S.
        • Briviba K.
        • Sies H.
        Carotenoid mixtures protect multilamellar liposomes against oxidative damage: synergistic effects of lycopene and lutein.
        FEBS Lett. 1998; 427: 305-308
        • Calder P.C.
        • Albers R.
        • Antoine J.M.
        • Blum S.
        • Bourdet-Sicard R.
        • Ferns G.A.
        • et al.
        Inflammatory disease processes and interactions with nutrition.
        Br J Nutr. 2009; 101: 1-45
        • Zillikens M.C.
        • van Meurs J.B.J.
        • Rivadeneira F.
        • Hofman A.
        • Oostra B.A.
        • Sijbrands E.J.G.
        • et al.
        Interactions between dietary vitamin E intake and SIRT1 genetic variation influence body mass index.
        Am J Clin Nutr. 2010; 91: 1387-1393
        • Brigelius-Flohé R.
        Vitamin E: the shrew waiting to be tamed.
        Free Radic Biol Med. 2009; 46: 543-554
        • Tim J.C.
        • Mary C.B.
        • Katherine M.F.
        • William H.D.
        Establishing a standard definition for child overweight and obesity worldwide: international survey.
        BMJ. 2000; 320: 1240
        • Martinez-Gomez D.
        • Gomez-Martinez S.
        • Puertollano M.A.
        • Nova E.
        • Warnberg J.
        • Veiga O.
        • et al.
        Design and evaluation of a treatment programme for Spanish adolescents with overweight and obesity. The EVASYON study.
        BMC Public Health. 2009; 9: 414
        • Tanner J.M.
        • Whitehouse R.H.
        Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty.
        Arch Dis Child. 1976; 51: 170-179
        • Topouchian J.A.
        • El Assaad M.A.
        • Orobinskaia L.V.
        • El Feghali R.N.
        • Asmar R.G.
        Validation of two automatic devices for self-measurement of blood pressure according to the International Protocol of the European Society of Hypertension: the Omron M6 (HEM-7001-E) and the Omron R7 (HEM 637-IT).
        Blood Press Monit. 2006; 11: 165-171
        • Wallach J.
        Interpretation of diagnostic tests.
        9th ed. Lippincott Williams & Wilkins, Philadelphia2011
        • Walldius G.
        • Jungner I.
        The apoB/apoA-I ratio: a strong, new risk factor for cardiovascular disease and a target for lipid-lowering therapy – a review of the evidence.
        J Intern Med. 2006; 259: 493-519
        • Hong K.
        • Li Z.
        • Wang H.J.
        • Elashoff R.
        • Heber D.
        Analysis of weight loss outcomes using VLCD in black and white overweight and obese women with and without metabolic syndrome.
        Int J Obes Relat Metab Disord. 2005; 29: 436-442
        • Codoner-Franch P.
        • Lopez-Jaen A.B.
        • De La Mano-Hernandez A.
        • Sentandreu E.
        • Simo-Jorda R.
        • Valls-Belles V.
        Oxidative markers in children with severe obesity following low-calorie diets supplemented with mandarin juice.
        Acta Paediatr. 2010; 99: 1841-1846
        • Walldius Gr
        • Jungner I.
        • Aastveit Are H.
        • Holme I.
        • Furberg Curt D.
        • Sniderman Allan D.
        The apoB/apoA-I ratio is better than the cholesterol ratios to estimate the balance between plasma proatherogenic and antiatherogenic lipoproteins and to predict coronary risk.
        Clin Chem Lab Med. 2004; 42: 1355-1363
        • Bonora E.
        • Kiechl S.
        • Willeit J.
        • Oberhollenzer F.
        • Egger G.
        • Meigs J.B.
        • et al.
        Population-based incidence rates and risk factors for type 2 diabetes in white individuals: the Bruneck study.
        Diabetes. 2004; 53: 1782-1789
        • Othman E.M.
        • Kreissl M.C.
        • Kaiser F.R.
        • Arias-Loza P.-A.
        • Stopper H.
        Insulin-mediated oxidative stress and DNA damage in LLC-PK1 pig kidney cell line, female rat primary kidney cells, and male ZDF rat kidneys in vivo.
        Endocrinology. 2013; 154: 1434-1443
        • Wunsch R.
        • de Sousa G.
        • Toschke A.M.
        • Reinehr T.
        Intima-media thickness in obese children before and after weight loss.
        Pediatrics. 2006; 118: 2334-2340
        • Reinehr T.
        • de Sousa G.
        • Toschke A.M.
        • Andler W.
        Long-term follow-up of cardiovascular disease risk factors in children after an obesity intervention.
        Am J Clin Nutr. 2006; 84: 490-496
        • McGill H.C.
        • McMahan C.A.
        • Herderick E.E.
        • Malcom G.T.
        • Tracy R.E.
        • Strong J.P.
        • et al.
        Origin of atherosclerosis in childhood and adolescence.
        Am J Clin Nutr. 2000; 72: 1307s-1315s